News.
Leaked Internal Memo From Fresenius Medical Regarding Granuflo and NaturaLyte Heart Attack Risk
Fresenius Medical Care, treats more than a third of the estimated 400,000 Americans receiving dialysis. It also is the leading supplier of dialysis machines and disposable products, which are used by many clinics in addition to its own.
Last November, Fresenius’s medical office sent an internal memo to doctors practicing in the company’s dialysis centers, warning them that failure to properly the company’s "Granuflo" and "NaturaLyte" products appeared to be contributing to a sharp increase in the risk of patients dying suddenly from cardiac arrest. A copy of that internal "Fresenius Medical Care North America" memorandum to doctors and attending physicians, dated November 4, 2011, is located here: http://audetlaw.com/documents/fresenius-memo.pdf
Important Notice
Persons seeking to preserve any potential legal claims should contact an attorney promptly, since all states have mandatory time periods in which lawsuits must be filed with the courts; otherwise, they may be forever barred.
About Audet and Partners, LLP
Audet & Partners represents individuals, governmental entities, small businesses and institutional shareholders in product liability, tort, negligence, consumer, construction defect, investment fraud, securities, insider trading, antitrust, environmental, whistle blower, aviation and employment cases. In recognition of their outstanding abilities and commitment to the legal profession over the years, the firm and its members have served as Court-appointed Plaintiffs’ Counsel in dozens of federal and state cases throughout the United States.
